130 related articles for article (PubMed ID: 16546532)
1. Renoprotective effects of renin-angiotensin-system inhibitors.
Parving HH; Rossing P
Lancet; 2006 Mar; 367(9514):898-9; author reply 900-2. PubMed ID: 16546532
[No Abstract] [Full Text] [Related]
2. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
Bilous R
Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
[No Abstract] [Full Text] [Related]
3. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
4. Renoprotective effects of renin-angiotensin-aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis.
Catalá-López F
Diabetologia; 2012 Sep; 55(9):2547-8; author reply 2549-50. PubMed ID: 22729654
[No Abstract] [Full Text] [Related]
5. Treating diabetic nephropathy: unfinished success is not failure.
Lewis J
Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
[No Abstract] [Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
7. [Type 2 diabetes and nephropathy--new studies, new treatment strategies?].
Os I; Stenehjem A; Høieggen A; Draganov B; Jenssen T; Holdaas H
Tidsskr Nor Laegeforen; 2002 Apr; 122(9):918-20. PubMed ID: 12082835
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus.
Parving HH
J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):30-1. PubMed ID: 11967794
[No Abstract] [Full Text] [Related]
9. Angiotensin receptors blockers are preferred to angiotensin-converting inhibitors [corrected].
Feldman L; Weissgarten J
Isr Med Assoc J; 2004 May; 6(5):299-300. PubMed ID: 15151374
[No Abstract] [Full Text] [Related]
10. Diabetes complications and the renin-angiotensin system.
Perkins BA; Aiello LP; Krolewski AS
N Engl J Med; 2009 Jul; 361(1):83-5. PubMed ID: 19571288
[No Abstract] [Full Text] [Related]
11. Kidney disease in diabetology: lessons from 2008.
Schernthaner G
Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896
[No Abstract] [Full Text] [Related]
12. [Dual blockade of the renin-angiotensin system].
Andersen NH; Mogensen CE
Ugeskr Laeger; 2004 Oct; 166(43):3799-803. PubMed ID: 15544108
[No Abstract] [Full Text] [Related]
13. Renin-angiotensin-aldosterone system blockade and urinary albumin excretion in community-based patients with Type 2 diabetes: the Fremantle Diabetes Study.
Fegan PG; Davis WA; Kamber N; Sivakumar S; Beilby J; Davis TM
Diabet Med; 2011 Jul; 28(7):849-55. PubMed ID: 21231957
[TBL] [Abstract][Full Text] [Related]
14. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Ravid M
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S410-3. PubMed ID: 19875590
[No Abstract] [Full Text] [Related]
15. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
16. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
Shionoiri H; Yasuda G; Takizawa T; Shionoiri F
Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
[No Abstract] [Full Text] [Related]
17. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
Ritz E
MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
[No Abstract] [Full Text] [Related]
18. [Debate concerning the optimal blockage of the renin-angiotensin system].
Choukroun G
Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
[No Abstract] [Full Text] [Related]
19. [Inhibition of the renin-angiotensin system in type 2 diabetes. New significant results concerning type 2 diabetes and renal disease].
Mogensen CE
Ugeskr Laeger; 2001 Oct; 163(40):5488. PubMed ID: 11601112
[No Abstract] [Full Text] [Related]
20. [Renoprotection and blockade of the renin-angiotensin system: What shall we believe?].
Kamper AL; Feldt-Rasmussen B; Strandgaard S
Ugeskr Laeger; 2006 Apr; 168(15):1563. PubMed ID: 16640988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
